Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sue Richards
Response: Chemotherapy Versus Allogeneic Transplantation in Adult Patients With Acute Lymphoblastic Leukemia in First Remission--Not a Time for Dogma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
Adults With Philadelphia-Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Bone Marrow Transplantation for Patients With Acute Lymphoblastic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients With Intermediate-Risk Acute Myelogenous Leukemia in First Complete Remission
Clinical Cancer Research
Cancer Research
Oncology
Remission to Transplantation Time in Acute Myeloid Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years With Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Hematopoietic Cell Transplantation in First Remission Abrogates Poor Outcomes Associated With High-Risk Pediatric Acute Myeloid Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Stem Cell Transplantation Outcomes in Acute Myeloid Leukemia Patients With T(8;21)(q22;q22) in First Remission According to Conditioning Regimen
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Haploidentical vs Autologous Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia Beyond First Remission
Bone Marrow Transplantation
Transplantation
Hematology
Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia
Blood Cancer Journal
Oncology
Hematology
